ESH Video

International Conference on Acute Lymphoblastic Leukaemia

International Conference on Acute Lymphoblastic Leukaemia
May 17 - May 19, 2019 - Berlin, Germany
Chairs : Jan Cools, Hervé Dombret, Adele Fielding, Mark Litzow


International Conference on
Berlin, Germany
May 17-19, 2019
Chairs: Jan Cools (Leuven), Hervé Dombret (Paris), Adele Fielding (London), Mark Litzow (Rochester)

Programme summary:
Major advances have been reached recently in the knowledge of acute lymphoblastic leukaemia (ALL), including the comprehensive description of B-cell precursor and T-cell ALL genomic landscapes, identi­ cation of new potentially druggable disease subsets and discovery of predisposing preleukemic events. During the same period of time, progresses have been accomplished in the management of children and adults with ALL, thanks to routine monitoring of measurable residual disease (MRD), administration of intensi­ ed risk-adapted chemotherapy, introduction of targeted therapies and antibodies, followed by the remarkable eff­icacy of antibody-drug conjugates (ADCs), bi speci­fic T-cell engager antibodies (BiTEs) and manufactured chimeric antigen receptor (CAR) T-cells.

This intense research activity has made ALL a fascinating disease, allowing major improvements in patients’ outcome, while providing important proofs of concept for the treatment of cancer in general.

The 1st ESH Translational Conference on ALL is designed to provide time and multiple opportunities for discussions and interactions with internationally recognized physicians and scientists in the ­field.


Learning objectives:

  • Learn how to optimally diagnose and classify ALL, by combining modern diagnosis algorithms and early MRD monitoring, to rapidly deliver the right treatment to the right patient
  • Review the conventional therapeutic options, with a focus on the role of allogeneic haematopoietic stem cell transplantation
  • Learn how to optimize the management of individual patients on the basis of individual drug metabolism, tolerance and toxicity
  • Acquire improved knowledge of new emerging targeted or immunologic treatments and understand how they might be combined or even eventually replace current conventional treatment options


The programme will include:

  • Plenary Sessions
  • Introductory and Keynote Lectures
  • Roundtables
  • Panel Discussions
  • Simultaneous Meet the Expert Sessions
  • Manned Poster Session




Abstract submission

Abstracts Submissions will open soon!


Abstracts guidelines

– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)
– Maximum number of words: 400
– Your abstract will be submitted to the peer review procedure.

The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).




Accommodation at special conference rates will be available here soon!

Vienna House Andels’ Berlin Hotel
Landsberger Allee 106,
10369, Berlin, Germany


Corporate partners




Registrations will open soon!

The registration fee for this conference is:
– Regular registration fee: 600€
– Registration fee for resident in-training: 300€ (support document required)

This fee includes :
Your place in the Conference Room,
Conference Materials,
Luncheons, Refreshments throughout the conference.

Your seat in the conference will be definitively reserved upon receipt of your fee.

Type of payment :

A) By Cheque :
ESH, Centre Hayem, Hôpital Saint Louis
1 Avenue Claude Vellefaux
75475 Paris Cedex 10

B) By Bank transfer :
Bank address: BNPParibas, 156 avenue Parmentier, 75010 Paris, France
Bank code: 30004. 
Agency code: 01730.
Account number: 00010099772. 
Control key: 92.
IBAN: FR 76 3000 4017 3000 0100 9977 292

C) By Credit card : VISA, MASTERCARD, AMEX

Cancellation policy of registration fee :
In case of cancellation, up until one month prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges).
If the cancellation is notified between 1 and 30 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges).
Cancellations notified during the meeting will not be reimbursed.